Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rieckmann

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
Neurodegenerative Disease Management|August 26, 2022
Disease stability over five years in people with multiple sclerosis treated with cladribine tablets: a plain language summaryGavin Giovannoni, Giancarlo Comi, Kottil Rammohan, et al.
BMC Neurology|September 15, 2012
Excitability decreasing central motor plasticity is retained in multiple sclerosis patientsDaniel Zeller, Su-Yin Dang, David Weise, et al.
Annals of Neurology|May 25, 2005
A PD-1 polymorphism is associated with disease progression in multiple sclerosisAntje Kroner, Matthias Mehling, Bernhard Hemmer, et al.
Journal of Neuroimmunology|October 7, 2006
Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controlsFelix Gronen, Klemens Ruprecht, Benedikt Weissbrich, et al.
Expert Opinion on Pharmacotherapy|July 14, 2020
Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinionSven G Meuth, Antonios Bayas, Boris Kallmann, et al.
Advances in Therapy|November 30, 2018
Adherence to Subcutaneous IFN β-1a in Multiple Sclerosis: Final Analysis of the Non-Interventional Study READOUTsmart Using the Dosing Log and Readout Function of RebiSmart<sup>®</sup>Peter Rieckmann, Matthias Schwab, Dieter Pöhlau, et al.
Immunogenetics|April 27, 2002
A polymorphism in the human cytotoxic T-lymphocyte antigen 4 ( CTLA4) gene (exon 1 +49) alters T-cell activationMathias Mäurer, Silke Loserth, Annette Kolb-Mäurer, et al.
Journal of Neurology|March 19, 2013
Multiple sclerosis in the Arabian Gulf countries: a consensus statementSaeed Bohlega, Jihad Inshasi, Abdel Rahman Al Tahan, et al.
Journal of Neuroimmunology|August 30, 2005
Subcutaneous interferon-beta injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine inductionMathias Buttmann, Matthias Goebeler, Atiye Toksoy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 29, 2002
Characteristic gene expression profile of primary human cerebral endothelial cellsBoris-A Kallmann, Sven Wagner, Vera Hummel, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Neurodegenerative Disease Management|August 26, 2022
Disease stability over five years in people with multiple sclerosis treated with cladribine tablets: a plain language summaryGavin Giovannoni, Giancarlo Comi, Kottil Rammohan, et al.
BMC Neurology|September 15, 2012
Excitability decreasing central motor plasticity is retained in multiple sclerosis patientsDaniel Zeller, Su-Yin Dang, David Weise, et al.
Annals of Neurology|May 25, 2005
A PD-1 polymorphism is associated with disease progression in multiple sclerosisAntje Kroner, Matthias Mehling, Bernhard Hemmer, et al.
Journal of Neuroimmunology|October 7, 2006
Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controlsFelix Gronen, Klemens Ruprecht, Benedikt Weissbrich, et al.
Expert Opinion on Pharmacotherapy|July 14, 2020
Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinionSven G Meuth, Antonios Bayas, Boris Kallmann, et al.
Advances in Therapy|November 30, 2018
Adherence to Subcutaneous IFN β-1a in Multiple Sclerosis: Final Analysis of the Non-Interventional Study READOUTsmart Using the Dosing Log and Readout Function of RebiSmart<sup>®</sup>Peter Rieckmann, Matthias Schwab, Dieter Pöhlau, et al.
Immunogenetics|April 27, 2002
A polymorphism in the human cytotoxic T-lymphocyte antigen 4 ( CTLA4) gene (exon 1 +49) alters T-cell activationMathias Mäurer, Silke Loserth, Annette Kolb-Mäurer, et al.
Journal of Neurology|March 19, 2013
Multiple sclerosis in the Arabian Gulf countries: a consensus statementSaeed Bohlega, Jihad Inshasi, Abdel Rahman Al Tahan, et al.
Journal of Neuroimmunology|August 30, 2005
Subcutaneous interferon-beta injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine inductionMathias Buttmann, Matthias Goebeler, Atiye Toksoy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 29, 2002
Characteristic gene expression profile of primary human cerebral endothelial cellsBoris-A Kallmann, Sven Wagner, Vera Hummel, et al.
Pageof 13